Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization of glycogen storage disease type III.

Current molecular medicine - 1 Mar 2002

Shen J J, Chen Y T

Abstract excerpt

Deficiency of the glycogen debranching enzyme (gene, AGL) causes glycogen storage disease type III (GSD-III), an autosomal recessive disease affecting glycogen metabolism. Most GSD-III patients have AGL deficiency in both the liver and muscle (type IIIa), but some have it in the liver but not muscle (type IIIb). Cloning of human AGL cDNAs and determination of the genomic structure and mRNA isoforms of AGL have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbohydrate Chemistry and Synthesis
Share to DNA, Complementary
Share to Gene Deletion

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glycogen

Share to Glycogen Debranching Enzyme System

Share to Glycogen Storage Diseases and Myoclonus

Share to Mutation

Share to Structure-Activity Relationship

Source

Identifiers

PMID: 11949933
DOI: 10.2174/1566524024605752

Genes

AGL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization of glycogen storage disease type III.PMID 11949933Read ↗

Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.Semantic proximity Read ↗

Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.Semantic proximity Read ↗

Molecular and clinical delineation of 12 patients with glycogen storage disease type III in Western Turkey.Semantic proximity Read ↗

Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3.Semantic proximity Read ↗

Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.Semantic proximity Read ↗

Spectrum of amyloglucosidase mutations in Asian Indian patients with Glycogen storage disease type III.Semantic proximity Read ↗

Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan.Semantic proximity Read ↗

Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease.Semantic proximity Read ↗

Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III.Semantic proximity Read ↗

Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle.Semantic proximity Read ↗

A mutation analysis of the AGL gene in Korean patients with glycogen storage disease type III.Semantic proximity Read ↗

Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.